Diabetes Is Not Associated With Increased Mortality in Emergency Department Patients With Sepsis - 19/10/11
Résumé |
Study objective |
Despite its high prevalence, the influence of diabetes on outcomes of emergency department (ED) patients with sepsis remains undefined. Our aim is to investigate the association of diabetes and initial glucose level with mortality in patients with suspected infection from the ED.
Methods |
Three independent, observational, prospective cohorts from 2 large US tertiary care centers were studied. We included patients admitted to the hospital from the ED with suspected infection. We investigated the association of diabetes and inhospital mortality within each cohort separately and then overall with logistic regression and generalized estimating equations adjusted for age, sex, disease severity, and sepsis syndrome. We also tested for an interaction between diabetes and hyperglycemia/hypoglycemia.
Results |
A total of 7,754 patients were included. The mortality rate was 4.3% (95% confidence interval [CI] 3.9% to 4.8%) and similar in diabetic and nondiabetic patients (4.1% versus 4.4%; absolute risk difference 0.4%; 95% CI –0.7% to 1.4%). There was no significant association between diabetes and mortality in adjusted analysis (odds ratio [OR] overall 0.85; 95% CI 0.71 to 1.01). Diabetes significantly modified the effect of hyperglycemia and hypoglycemia with mortality; initial glucose levels greater than 200 mg/dL were associated with higher mortality in nondiabetic patients (OR 2.1; 95% CI 1.4 to 3.0) but not in diabetic patients (OR 1.0; 95% CI 0.2 to 4.7), whereas glucose levels less than 100 mg/dL were associated with higher mortality mainly in the diabetic population (OR 2.3; 95% CI 1.6 to 3.3) and to a lesser extent in nondiabetic patients (OR 1.1; 95% CI 1.03 to 1.14).
Conclusion |
We found no evidence for a harmful association of diabetes and mortality in patients across different sepsis severities. High initial glucose levels were associated with adverse outcomes in the nondiabetic population only. Further investigation is warranted to determine the mechanism for these effects.
Le texte complet de cet article est disponible en PDF.Plan
Please see page 439 for the Editor's Capsule Summary of this article. |
|
Provide process.asp?qs_id=7093 on this article at the journal's Web site, www.annemergmed.com. |
|
A podcast for this article is available at www.annemergmed.com. |
|
Supervising editor: Gregory J. Moran, MD |
|
Author contributions: PS and NIS conceived of the study, conducted the analysis, and wrote the first draft. AEJ, MDH, ST, LN, JGY, and WA commented on the first draft, and all authors approved the final article. PS and NS take responsibility for the paper as a whole. |
|
Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org). Dr. Schuetz was supported by a research grant from the Swiss Foundation for Grants in Biology and Medicine (Schweizerische Stiftung für medizinisch-biologische Stipendien, SSMBS, PASMP3-127684/1) and the Prof. Max Cloetta Stiftung. Dr. Shapiro was supported in part by National Institutes of Health (NIH) grants HL091757 and GM076659. Dr. Jones was supported by a grant from the National Institute of General Medical Sciences GM076652. Dr. Ngo was supported by the Harvard Clinical and Translational Science Center (NIH award UL1 RR 025758). |
|
Publication date: Available online June 16, 2011. |
Vol 58 - N° 5
P. 438-444 - novembre 2011 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?